Valuation Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 21:00:02 16/06/2026 BST			5-day change	1st Jan Change
184.79 ^USD	-1.95%		-0.89%	-7.36%

06-05	Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says	MT
06-03	Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 09:55 AM

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,941	11,138	12,252	9,520	10,023	8,901	-	-
Change	-	-41.2%	10%	-22.3%	5.29%	-11.2%	-	-
Enterprise Value (EV) ¹	21,366	13,616	14,622	11,565	11,946	10,713	10,369	9,992
Change	-	-36.28%	7.39%	-20.91%	3.29%	-10.32%	-3.21%	-3.63%
P/E Ratio	49.4x	23.1x	25.9x	931x	-70x	30.1x	20.1x	18.4x
PBR	7.45x	3.75x	3.41x	2.75x	3.17x	2.7x	2.45x	2.23x
PEG	-	0.9x	-9.44x	-9.5x	0x	-0x	0.4x	1.95x
Capitalization / Revenue	5.35x	2.8x	2.97x	2.35x	2.5x	2.31x	2.27x	2.17x
EV / Revenue	6.04x	3.42x	3.54x	2.86x	2.98x	2.78x	2.64x	2.43x
EV / EBITDA	24.3x	13.7x	14.4x	11.6x	12.3x	10.9x	9.92x	8.99x
EV / EBIT	28.8x	16.3x	17.4x	14.3x	15x	13.2x	11.8x	10.5x
EV / FCF	40.2x	46.2x	40x	23.1x	23x	30.8x	26.4x	41.7x
FCF Yield	2.49%	2.17%	2.5%	4.34%	4.34%	3.25%	3.79%	2.4%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	7.6	9.48	9.22	0.2	-2.91	6.135	9.2	10.07
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	3,540	3,976	4,129	4,050	4,015	3,855	3,924	4,105
EBITDA ¹	879.5	990.9	1,013	996.1	971.5	986.4	1,046	1,111
EBIT ¹	742.1	834	838.8	805.9	793.9	813.2	881	947.2
Net income ¹	391	486.2	474.6	10.3	-144.3	285.1	417.2	449
Net Debt ¹	2,425	2,477	2,370	2,046	1,923	1,812	1,468	1,091
Reference price ²	375.34	218.92	238.84	186.16	203.66	184.79	184.79	184.79
Nbr of stocks (in thousands)	50,464	50,879	51,297	51,136	49,215	48,168	-	-
Announcement Date	16/02/22	22/02/23	14/02/24	19/02/25	18/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	30.72x	2.83x	11.04x	-.--%	9.08B
LONZA GROUP AG	29.89x	5.3x	16.42x	1.1%	43.58B
REVOLUTION MEDICINES, INC.	-20.13x	298.25x	-18.37x	-.--%	34.03B
IQVIA HOLDINGS INC.	21.71x	2.51x	10.86x	-.--%	29.77B
BEONE MEDICINES AG	40.01x	3.98x	25.46x	-.--%	29.82B
CELLTRION, INC.	29.57x	7.61x	19.57x	0.4%	25.42B
MEDPACE HOLDINGS, INC.	27.44x	4.4x	20.03x	-.--%	13.35B
EUROFINS SCIENTIFIC SE	22.01x	1.91x	8.41x	1.21%	12.85B
IONIS PHARMACEUTICALS, INC.	-20.49x	13.48x	-20.07x	-.--%	12.22B
Average	17.86x	37.81x	8.15x	0.3%	23.35B
Weighted average by Cap.	18.50x	52.54x	9.05x	0.35%